1,4-ANHYDRO-2,3,5-TRIDEOXY-4-C-(2,4-DIFLUOROPHENYL)-2-((4-(4-(4-(1-((1R,2S)-1-ETHYL-2-HYDROXYPROPYL)-1,5-DIHYDRO-5-OXO-4H-1,2,4-TRIAZOL-4-YL)PHENYL)-1-PIPERAZINYL)PHENOXY)METHYL)-5-(1H-1,2,4-TRIAZOL-1-YL)-D-ERYTHRO-PENTITOL
UNII LE563B6RN8
Substance Identification & Data
This profile provides standardized clinical and technical data for 1,4-anhydro-2,3,5-trideoxy-4-c-(2,4-difluorophenyl)-2-((4-(4-(4-(1-((1r,2s)-1-ethyl-2-hydroxypropyl)-1,5-dihydro-5-oxo-4h-1,2,4-triazol-4-yl)phenyl)-1-piperazinyl)phenoxy)methyl)-5-(1h-1,2,4-triazol-1-yl)-d-erythro-pentitol, uniquely identified by the FDA Unique Ingredient Identifier (UNII) LE563B6RN8.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 213381-04-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C37H42F2N8O4 RAGOYPUPXAKGKH-DCLTZVOKSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 1,4-anhydro-2,3,5-trideoxy-4-c-(2,4-difluorophenyl)-2-((4-(4-(4-(1-((1r,2s)-1-ethyl-2-hydroxypropyl)-1,5-dihydro-5-oxo-4h-1,2,4-triazol-4-yl)phenyl)-1-piperazinyl)phenoxy)methyl)-5-(1h-1,2,4-triazol-1-yl)-d-erythro-pentitol. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.